Collaboration aims to develop sector
There's fresh impetus for growth in the Island's niche BioMed sector.
A new Manx Healthcare and Life Sciences Advisory Board has been formed, in a partnership between government and the private sector.
It's a collaboration designed to support the cluster, which employs more than 100 staff, and has grown by 13% since it was established in 2013.
The 11 firms currently based here are involved in diverse areas - from device manufacture and clinical trials, to compliance affairs and data capture.
The Advisory Board comprises representatives from the Departments of Economic Developemt and Health and Social Care, industry entrepreneurs and academics.
The move stems from a sector strategy created in 2016, which aims to identify new opportunities, assist existing businesses, attract companies to locate in the Island and ultimately, diversify the Manx economy.
Board member Dave Taggart from Glycyx Therapeutics gave his assessment of the sector's prospects:
Hospitality bosses to attend 'call to arms' meeting
Rate of inflation falls to 3.2%
Business will suffer 'significant' loss during the TT
TT merchandise provider makes upfront payment for contract
Hunt for new Steam Packet non-executives
Public disappointment after decision to sell ex-Newson's buildings
